MEDROXYPROGESTERONE ACETATE
Generic: MEDROXYPROGESTERONE ACETATE
Eugia US LLCManufacturer
INTRAMUSCULARRoute
MEDROXYPROGESTERONE ACETATEActive Substance
2022-08-22Original Approval
MEDROXYPROGESTERONE ACETATE is FDA application ANDA212824, sponsored by EUGIA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-05-06
medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Prefilled Syringe, 150 mg/mL, Rx only, Manufactured by Sun Lack of assurance of sterility
Class II2024-12-18
medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only, 1 mL Single-Dose Vial, Mfd in India for: CGMP Deviations
Top Reported Reactions
1
BREAST CANCER FEMALE
2,993 reports
2
BREAST CANCER
1,819 reports
3
MENINGIOMA
774 reports
4
BREAST CANCER METASTATIC
434 reports
5
DRUG INEFFECTIVE
306 reports
6
OFF LABEL USE
229 reports
7
OESTROGEN RECEPTOR ASSAY POSITIVE
215 reports
8
PAIN
195 reports
9
OVARIAN CANCER
184 reports
10
NAUSEA
180 reports